Clinical Trials · NCT01424241
Effects of Sandostatin LAR® in Acromegaly
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Columbia University
- Enrollment
- 21
- Start date
- Oct 2006
- Locations
- 1 site, United States
- Primary endpoint
- IGF-1 Level on Sandostatin LAR